)
)
)
Yves Dudal
CEO
,
Perseo pharma AG
Switzerland
Biotech engineer and scientist as background
Entrepreneur since 2010 in various biotech fields, pharma since 2019.
Raised USD 10m for preclinical stage Perseo pharma since 2019
Secured a collaboration with big pharma leading to a licensing deal in 2025.
Sessions
-
Perseo pharma AG02-Mar-2026Ballroom II C
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
